AIIMS breakthrough may lead to world's first oral Hepatitis
Researchers at the All India Institute of Medical Sciences (AIIMS) have developed nano-particles loaded with antigen protein segments that could lead to the discovery of an oral hepatitis B vaccine.
“The outcomes are positive in animal studies and if human trials are successful as well, an oral vaccine for hepatitis B could become a reality by 2021, doing away with the need for injections and booster doses,” said Dr Amit Dinda, professor of pathology at the AIIMS, who led the research.
Read more:
V●●●●●a G●●●●o and 44 others like this
Dr. G●●●●h B●●u
Dr. G●●●●h B●●u Paediatrics
That is not research changing drug delivery from one method to other if they reachers find drugs for incurable diseases
Jun 8, 2016Like
Dr. Q●●●r S●●●●●●i
Dr. Q●●●r S●●●●●●i General Surgery
Jun 11, 2016Like
S●●●●●m M●●●●a
S●●●●●m M●●●●a General Medicine
Jun 21, 2016Like